21 May 2013
Keywords: revisions, orphan, drug, act, congressional, hearing, revise
Article | 27 January 1992
At a congressional hearing to revise the current Orphan Drug Act by
limiting incentives for companies to develop these drugs, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 1992
20 May 2013
© 2013 thepharmaletter.com